Answers are grounded in this paper and cite their sources.
Review highlights trends in deviation management and CAPA in API manufacturing, suggesting advancements like AI and blockchain may enhance compliance.
The review explores the trends, problems, and developments in the management of deviations and Corrective and Preventive Actions (CAPAs) in Active Pharmaceutical Ingredient (API) manufacturing. This analysis underscores the essential function of effective deviation management systems in upholding compliance, guaranteeing product quality, and mitigating risks through the examination of historical changes, statistical data, and case studies. The essay examines legal consequences and suggests future approaches, including the use of new technologies such as AI, digital transformation, and blockchain, to improve proactive and efficient CAPA processes. These innovations are crucial for enhancing operational excellence and conforming to changing regulatory norms.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: